Charles M. Baum

Companies

• Acrivon Therapeutics, Inc.Board member Jun 28, 2023 to now¹
• PMV Pharmaceuticals, Inc.Board member Apr 7, 2021 to now²
• Poseida Therapeutics, Inc.Board member May 18, 2022 to Jan 8, 2025³
• Mirati Therapeutics, Inc.Board member Jul 12, 2013 to Jan 23, 2024⁴
• Mirati Therapeutics, Inc.Chief executive officer Jul 12, 2013 to Jan 23, 2024⁴
• Mirati Therapeutics, Inc.President Jul 12, 2013 to Jan 23, 2024⁴
• Tango Therapeutics (United States)Board member Sep 2, 2020 to Sep 2, 2020⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAcrivon Therapeutics, Inc. ACRV9,366 shares⁶$15.4K at $1.64May 18, 2026
• MTMirati Therapeutics, Inc.0 shares⁷Jan 23, 2024
• PTPoseida Therapeutics, Inc.0 shares⁸Jan 8, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• May 18, 2026Granted 9,366 shares of Acrivon Therapeutics, Inc.⁶
• Jan 8, 2025U 78,600 shares of Poseida Therapeutics, Inc.⁸
• Jun 17, 2024Granted 19,650 shares of Poseida Therapeutics, Inc.⁹
• Jan 23, 2024Returned to company 20,425 shares of Mirati Therapeutics, Inc.⁷
• Jan 23, 2024Returned to company 94,057 shares of Mirati Therapeutics, Inc.⁷
• Jan 23, 2024Returned to company 123,389 shares of Mirati Therapeutics, Inc.⁷
• Dec 29, 2023Granted 20,425 shares at $58.75 of Mirati Therapeutics, Inc.¹⁰
• Aug 9, 2023Granted 54,054 shares at $37.00 of Mirati Therapeutics, Inc.¹¹
• Jun 15, 2023Granted 19,650 shares of Poseida Therapeutics, Inc.¹²
• Jan 20, 2023Granted 4,444 shares of Mirati Therapeutics, Inc.¹³
• Jan 4, 2023Sold 3,648 shares at $46.60 of Mirati Therapeutics, Inc.¹⁴
• Dec 21, 2022Sold 9,092 shares at $40.42 of Mirati Therapeutics, Inc.¹⁵
• Dec 19, 2022Granted 53,618 shares of Mirati Therapeutics, Inc.¹⁵
• Nov 28, 2022Sold 69,256 shares at $100.00 of Mirati Therapeutics, Inc.¹⁶
• Nov 28, 2022Exercised options 69,256 shares at $17.41 of Mirati Therapeutics, Inc.¹⁶
• Jun 16, 2022Granted 39,300 shares of Poseida Therapeutics, Inc.¹⁷
• Jan 18, 2022Sold 2,517 shares at $120.48 of Mirati Therapeutics, Inc.¹⁸
• Jan 18, 2022Exercised options 3,703 shares at $27.00 of Mirati Therapeutics, Inc.¹⁸
• Jan 14, 2022Granted 25,543 shares of Mirati Therapeutics, Inc.¹⁸
• Jan 4, 2022Sold 69 shares at $149.09 of Mirati Therapeutics, Inc.¹⁹
• Jan 4, 2022Sold 4,045 shares at $147.73 of Mirati Therapeutics, Inc.¹⁹
• Dec 16, 2021Gift 7,430 shares of Mirati Therapeutics, Inc.²⁰
• Dec 3, 2021Sold 985 shares at $137.56 of Mirati Therapeutics, Inc.²¹
• Dec 3, 2021Sold 1,210 shares at $136.66 of Mirati Therapeutics, Inc.²¹
• Dec 3, 2021Sold 6,558 shares at $135.64 of Mirati Therapeutics, Inc.²¹